Raja SG, Fida N. Should angiotensin converting enzyme inhibitors/an- giotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation? Interact Cardiovasc Thorac Surg. 2008;7:470 5. 639. Levin R, Leacche M, Petracek MR, et al. Extending the use of the pacing pulmonary artery catheter for safe minimally invasive cardiac surgery. J Cardiothorac Vasc Anesth. 2010;24:568 73. 640. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Asso- ciation Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) [published correction appears in Circulaton 2005;111:2014]. Circulation. 2004; 110:e340 437. 641. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233 9. 642. Hilleman DE, Mohiuddin SM, Packard KA. Comparison of conser- vative and aggressive smoking cessation treatment strategies following coronary artery bypass graft surgery. Chest. 2004;125:435 8. 643. Rigotti NA, Munafo MR, Stead LF. Smoking cessation interventions for hospitalized smokers: a systematic review. Arch Intern Med. 2008; 168:1950 60. 644. Smith PM, Burgess E. Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial. CMAJ. 2009;180:1297 303. 645. Cavender JB, Rogers WJ, Fisher LD, et al., CASS Investigators. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10 year follow-up. J Am Coll Cardiol. 1992;20:287 94. 646. Vlietstra RE, Kronmal RA, Oberman A, et al. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS registry. JAMA. 1986; 255:1023 7. 647. 